Menu

1 / 2

Agilent Technologies: A Recovery Already Priced In

All Articles on Seeking Alpha·about 7 hours ago
#RNTcHrsp
#seekingalpha#seeking#alpha#technologies#sell
Reading 0:00
15s threshold

Home

Healthcare

Summary

Agilent Technologies (A) is a moderate-conviction SELL at $173.01: 34.1x trailing GAAP earnings leaves insufficient risk-adjusted upside despite improving fundamentals.

My November 2029 scenarios imply $92 bear, $161 base and $247 bull outcomes; the base case delivers approximately −1.7% annualized including dividends.

A’s installed base supports recurring revenue and attractive margins, but cyclical equipment demand and acquisition execution remain important risks.

I would sell the position rather than await November 23 earnings, then reassess fiscal 2027 demand, margins, cash flow and pathology integration.

Getty Images

SELL (MODERATE Confidence)

As of market close (4:00 p.m. Eastern) on November 12, 2026, Agilent Technologies ( NYSE: A ) shares last traded at $173.01.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.